Skip to main content
. 2021 Jan 29;100(4):e24475. doi: 10.1097/MD.0000000000024475

Table 2.

Support measures offered during the course of coronavirus disease 2019, by patient group.

Arbidoln = 40 Arbidol+LHn = 68 P value
Double nasal catheter for oxygen 13 (32.5%) 20 (29.4%) .737
Immunoglobulin therapy 9 (22.5%) 19 (27.9%) .533
Corticosteroid therapy 4 (10.0%) 10 (14.7%) .482
Number of antibacterial therapy agents 24 (60.0%) 43 (63.2%) .738
Invasive ventilation 0 (0.0%) 0 (0.0%)
Vasopressor therapy 0 (0.0%) 0 (0.0%)

Data were expressed as n (%).